A pilot, open-label, randomized, comparative study of the antiviral efficacy of lopinavir/ritonavir single-drug regimen versus lopinavir/ritonavir in combination with lamivudine/zidovudine in antiretroviral naive patients

Trial Profile

A pilot, open-label, randomized, comparative study of the antiviral efficacy of lopinavir/ritonavir single-drug regimen versus lopinavir/ritonavir in combination with lamivudine/zidovudine in antiretroviral naive patients

Completed
Phase of Trial: Phase III

Latest Information Update: 28 May 2015

At a glance

  • Drugs Lamivudine/zidovudine (Primary) ; Lopinavir/ritonavir (Primary)
  • Indications HIV infections; HIV-1 infections
  • Focus Registrational; Therapeutic Use
  • Acronyms MONARK
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 Jul 2009 Results of resistance analysis published in Antimicrobial Agents and Chemotherapy.
    • 02 Apr 2008 Status changed from in progress to completed according to ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top